PDF(Pubmed)
Abstract：
Here, we describe the case of a 43-year-old male patient with a metastatic parathyroid carcinoma who underwent dual-tracer whole-body positron emission tomography/computed tomography (PET/CT) with [18F]fluorocholine and fluorodeoxyglucose ([18F]FDG) for staging. [18F]FDG PET/CT detected multiple cervical and mediastinal lymph nodal lesions with increased tracer uptake, whereas [18F]fluorocholine PET/CT detected increased tracer uptake on cervical and mediastinal lymph nodal lesions and bone and lung lesions with a better evaluation of metastatic spread. Due to these imaging findings, the patient underwent systemic treatment with chemotherapy. This case demonstrates the added value of dual-tracer PET/CT in this rare metastatic tumor.
摘要：
这里,我们描述了1例患有转移性甲状旁腺癌的43岁男性患者,该患者接受了[18F]氟胆碱和氟脱氧葡萄糖([18F]FDG)双示踪剂全身正电子发射断层扫描/计算机断层扫描(PET/CT)分期.[18F]FDGPET/CT检测到颈部和纵隔淋巴结多发病变，示踪剂摄取增加，而[18F]氟胆碱PET/CT检测到宫颈和纵隔淋巴结病变以及骨和肺病变的示踪剂摄取增加，对转移扩散的评估更好。由于这些影像学发现，患者接受了全身化疗.此病例证明了双示踪剂PET/CT在这种罕见的转移性肿瘤中的附加价值。
